Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
Recruiting · NCT06394830 · Registry updated 2026-01-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, cystitis, interstitial cystitis, urinary bladder disorder, urinary system disorder | Recruiting | Phase 2 | 2026-01-22 | NCT06394830 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Prevail Infoworks | 3 |
| Vaneltix Pharma, Inc. | 2 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Arizona Urology Specialists | Tucson | United States | 5 |
| Georgia Urology | Cartersville | United States | 2 |
| Oregon Urology Institute | Springfield | United States | 14 |
| Prestige Medical Group | Tustin | United States | 7 |
| Valley Urology, Inc. | Fresno | United States | 1 |